Trial Outcomes & Findings for Clinical Comparison of Two Marketed Reusable Cosmetic Contact Lenses (NCT NCT03755882)
NCT ID: NCT03755882
Last Updated: 2020-02-05
Results Overview
Monocular visual performance (logMAR) was evaluated under 3 conditions (1.high luminance and high contrast, 2. High Lumiance Low Contrast and 3. Low Luminance High Contrast with distance goggles) at 4 meters using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Letter-by-letter results were calculated to ascertain the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20.
COMPLETED
NA
46 participants
Up to 2-Week Follow-up
2020-02-05
Participant Flow
A total of 46 subjects were enrolled into this study. Of those enrolled 45 were dispensed at least 1 study lens. Of those dispensed, 41 subjects completed the study while 4 were discontinued.
Participant milestones
| Measure |
Test/Control
Subjects randomized to this sequence received the Test lens during the first period and then received the Control lens during the second period
|
Control/Test
Subjects randomized to this sequence received the Control lens during the first period and then received the Test lens during the second period
|
|---|---|---|
|
Period 1
STARTED
|
23
|
22
|
|
Period 1
COMPLETED
|
19
|
22
|
|
Period 1
NOT COMPLETED
|
4
|
0
|
|
Period 2
STARTED
|
19
|
22
|
|
Period 2
COMPLETED
|
19
|
22
|
|
Period 2
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
| Measure |
Test/Control
Subjects randomized to this sequence received the Test lens during the first period and then received the Control lens during the second period
|
Control/Test
Subjects randomized to this sequence received the Control lens during the first period and then received the Test lens during the second period
|
|---|---|---|
|
Period 1
Protocol Violation
|
1
|
0
|
|
Period 1
Unsatisfactory Lens Fitting Test Article
|
3
|
0
|
Baseline Characteristics
Clinical Comparison of Two Marketed Reusable Cosmetic Contact Lenses
Baseline characteristics by cohort
| Measure |
Total
n=45 Participants
All subjects dispensed a study lens
|
|---|---|
|
Age, Continuous
|
23.6 years
STANDARD_DEVIATION 2.80 • n=5 Participants
|
|
Sex: Female, Male
Female
|
45 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
45 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
China
|
45 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 2-Week Follow-upPopulation: All subjects who had successfully completed all visits.
Monocular visual performance (logMAR) was evaluated under 3 conditions (1.high luminance and high contrast, 2. High Lumiance Low Contrast and 3. Low Luminance High Contrast with distance goggles) at 4 meters using Early Treatment Diabetic Retinopathy Study (ETDRS) charts. Letter-by-letter results were calculated to ascertain the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20.
Outcome measures
| Measure |
Test (Etafilcon A)
n=90 Eyes
Subjects that wore the Test lens in either the first or second period of the study.
|
Control (Hefilcon A)
n=82 Eyes
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Visual Performance
High Luminnance Low Contrast
|
0.40 logMAR Units
Standard Deviation 0.074
|
0.38 logMAR Units
Standard Deviation 0.086
|
|
Visual Performance
High Luminance High Contrast
|
-0.09 logMAR Units
Standard Deviation 0.053
|
-0.10 logMAR Units
Standard Deviation 0.059
|
|
Visual Performance
Low Luminance High Contrast with Distance Goggles
|
-0.10 logMAR Units
Standard Deviation 0.055
|
-0.09 logMAR Units
Standard Deviation 0.055
|
Adverse Events
Test (Etafilcon A)
Control (Hefilcon A)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Brian Pall, OD, MS, FAAO- Director of clinical Sciences
Johnson & Johnson Vision Care Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60